Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression
David A. Jacobsohn(Children's National), Michael A. Pulsipher(Primary Children's Hospital), Michelle Hudspeth(Medical University of South Carolina), Robert Greiner(Penn State Health Children's Hospital), Troy C. Quigg(CHRISTUS Transplant Institute), Mingwei Fei(Medical College of Wisconsin), Alexandra Cheerva(Kosair Children's Hospital), Terry J. Fry(University of Colorado Anschutz Medical Campus), Kimberly A. Kasow(University of North Carolina at Chapel Hill), Süreyya Savaşan(Children's Hospital of Michigan), Andrew C. Harris(Primary Children's Hospital), Pierre Teira(Université de Montréal), Brent R. Logan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Alfred P. Gillio(University Medical Center), Sanjay Ahuja(McMaster University), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Monica Bhatia(Columbia University Irving Medical Center), Eneida R. Nemecek(Oregon Health & Science University), David M. Loeb(Albert Einstein College of Medicine), Marie Olszewski(Lurie Children's Hospital), Christopher C. Dvorak(University of California, San Francisco), Morris Kletzel(Lurie Children's Hospital), Soheil Meshinchi(Fred Hutch Cancer Center), Victor Lewis(Alberta Children's Hospital), Amy K. Keating(Boston Children's Hospital), Kirk R. Schultz(University of British Columbia), Michael R. Loken(Unknown), Alexia Adams(National Marrow Donor Program), Ann E. Haight, Lisa Eidenschink Brodersen, David Mitchell(Montreal Children's Hospital), Allen Chen(Johns Hopkins University), Julie‐An Talano(Dana-Farber Cancer Institute), Aleksandra Petrović(Seattle Children's Hospital), Shalini Shenoy(Washington University in St. Louis), Paul L. Martin(Duke University), Jeffrey Davis(BC Children's Hospital), Michael W. Boyer(University of Utah), Reggie Duerst(Lurie Children's Hospital), M. Fevzi Özkaynak(Westchester Medical Center), David Delgado(Indiana University Hospital), Barbara Bambach(Roswell Park Comprehensive Cancer Center), Madhu Gowda(Virginia Commonwealth University), Roberta H. Adams(Mayo Clinic in Arizona), Sana Khan(Lurie Children's Hospital), Albert Kheradpour(Loma Linda University Medical Center), Kwang Woo Ahn(Medical College of Wisconsin), Steven Margossian(Boston Children's Hospital), Hilary Haines(Children's of Alabama)
Cited by 44
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse
|Journal of Clinical Oncology|2001|898
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
|Journal of Clinical Oncology|2011|839